Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 1999 May 15;340(Pt 1):237–243.

Enhancing activity and phospholipase A2 activity: two independent activities present in the enhancing factor molecule.

S Kadam 1, R Mulherkar 1
PMCID: PMC1220243  PMID: 10229680

Abstract

Enhancing factor (EF), a molecule that increases the binding of epidermal growth factor (EGF) to A431 cells, was first isolated in our laboratory from mouse intestines, and subsequently shown to be a secretory form of phospholipase A2 (PLA2) [Mulherkar, Rao, Wagle, Patki and Deo (1993) Biochem. Biophys. Res. Commun. 195, 1254-1263]. We had proposed earlier that EF increases the binding of EGF by first binding to its own cell-surface receptor [identified as a 100 kDa molecule; Mulherkar and Deo (1986) J. Cell. Physiol. 127, 183-188], and then by creating a binding site for EGF. However, due to its PLA2 activity, there was a possibility that EF, by its phospholipase activity could be unmasking cryptic EGF receptors on the cell surface, thereby increasing the number of binding sites for EGF. To test whether enhancing activity and phospholipase activity are independent of each other, a series of mutations were created using the full-length EF cDNA as a template, expressed in 293 cells and the mutant recombinant proteins checked for EF as well as PLA2 activities. Our studies have shown that one of the mutant EF proteins, lacking PLA2 activity, retains EF activity. This demonstrates unambiguously that EF and PLA2 activities are two independent activities in the same molecule. Mutation in the Ca2+-binding loop resulted in loss of EF activity, thereby demonstrating that EF activity is Ca2+-dependent. The N-terminal region of the EF molecule appears to be crucial for the enhancing activity.

Full Text

The Full Text of this article is available as a PDF (157.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bairoch A. The PROSITE dictionary of sites and patterns in proteins, its current status. Nucleic Acids Res. 1993 Jul 1;21(13):3097–3103. doi: 10.1093/nar/21.13.3097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Balsinde J., Barbour S. E., Bianco I. D., Dennis E. A. Arachidonic acid mobilization in P388D1 macrophages is controlled by two distinct Ca(2+)-dependent phospholipase A2 enzymes. Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):11060–11064. doi: 10.1073/pnas.91.23.11060. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Barbour S. E., Dennis E. A. Antisense inhibition of group II phospholipase A2 expression blocks the production of prostaglandin E2 by P388D1 cells. J Biol Chem. 1993 Oct 15;268(29):21875–21882. [PubMed] [Google Scholar]
  4. Bry L., Falk P., Huttner K., Ouellette A., Midtvedt T., Gordon J. I. Paneth cell differentiation in the developing intestine of normal and transgenic mice. Proc Natl Acad Sci U S A. 1994 Oct 25;91(22):10335–10339. doi: 10.1073/pnas.91.22.10335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Clark J. D., Lin L. L., Kriz R. W., Ramesha C. S., Sultzman L. A., Lin A. Y., Milona N., Knopf J. L. A novel arachidonic acid-selective cytosolic PLA2 contains a Ca(2+)-dependent translocation domain with homology to PKC and GAP. Cell. 1991 Jun 14;65(6):1043–1051. doi: 10.1016/0092-8674(91)90556-e. [DOI] [PubMed] [Google Scholar]
  6. Davidson F. F., Dennis E. A. Evolutionary relationships and implications for the regulation of phospholipase A2 from snake venom to human secreted forms. J Mol Evol. 1990 Sep;31(3):228–238. doi: 10.1007/BF02109500. [DOI] [PubMed] [Google Scholar]
  7. Deo M. G., Mulherkar R., Mane S. M. Isolation of a polypeptide that enhances cellular binding of epidermal growth factor. Indian J Biochem Biophys. 1983 Aug;20(4):228–231. [PubMed] [Google Scholar]
  8. Desai S. J., Mulherkar R., Wagle A. S., Deo M. G. Ontogeny of enhancing factor in mouse intestines and skin. Histochemistry. 1991;96(4):371–374. doi: 10.1007/BF00271359. [DOI] [PubMed] [Google Scholar]
  9. Diccianni M. B., Lilly-Stauderman M., McLean L. R., Balasubramaniam A., Harmony J. A. Heparin prevents the binding of phospholipase A2 to phospholipid micelles: importance of the amino-terminus. Biochemistry. 1991 Sep 17;30(37):9090–9097. doi: 10.1021/bi00101a026. [DOI] [PubMed] [Google Scholar]
  10. Diccianni M. B., Mistry M. J., Hug K., Harmony J. A. Inhibition of phospholipase A2 by heparin. Biochim Biophys Acta. 1990 Oct 1;1046(3):242–248. doi: 10.1016/0005-2760(90)90237-r. [DOI] [PubMed] [Google Scholar]
  11. Dijkstra B. W., Drenth J., Kalk K. H., Vandermaelen P. J. Three-dimensional structure and disulfide bond connections in bovine pancreatic phospholipase A2. J Mol Biol. 1978 Sep 5;124(1):53–60. doi: 10.1016/0022-2836(78)90146-8. [DOI] [PubMed] [Google Scholar]
  12. Dijkstra B. W., Kalk K. H., Hol W. G., Drenth J. Structure of bovine pancreatic phospholipase A2 at 1.7A resolution. J Mol Biol. 1981 Mar 25;147(1):97–123. doi: 10.1016/0022-2836(81)90081-4. [DOI] [PubMed] [Google Scholar]
  13. Dua R., Cho W. Inhibition of human secretory class II phospholipase A2 by heparin. Eur J Biochem. 1994 Apr 1;221(1):481–490. doi: 10.1111/j.1432-1033.1994.tb18761.x. [DOI] [PubMed] [Google Scholar]
  14. Elsbach P., Weiss J. Utilization of labeled Escherichia coli as phospholipase substrate. Methods Enzymol. 1991;197:24–31. doi: 10.1016/0076-6879(91)97130-q. [DOI] [PubMed] [Google Scholar]
  15. Ishizaki J., Ohara O., Nakamura E., Tamaki M., Ono T., Kanda A., Yoshida N., Teraoka H., Tojo H., Okamoto M. cDNA cloning and sequence determination of rat membrane-associated phospholipase A2. Biochem Biophys Res Commun. 1989 Aug 15;162(3):1030–1036. doi: 10.1016/0006-291x(89)90777-8. [DOI] [PubMed] [Google Scholar]
  16. Kadam S., Deshpande C., Coulier F., Mulherkar R. Sequence analysis of full length cDNA for enhancing factor/phospholipase A2. Indian J Exp Biol. 1998 Jun;36(6):553–558. [PubMed] [Google Scholar]
  17. Kennedy B. P., Payette P., Mudgett J., Vadas P., Pruzanski W., Kwan M., Tang C., Rancourt D. E., Cromlish W. A. A natural disruption of the secretory group II phospholipase A2 gene in inbred mouse strains. J Biol Chem. 1995 Sep 22;270(38):22378–22385. doi: 10.1074/jbc.270.38.22378. [DOI] [PubMed] [Google Scholar]
  18. Mulherkar R., Deo M. G. Further studies on the enhancing factor and its possible mechanism of action. J Cell Physiol. 1986 Apr;127(1):183–188. doi: 10.1002/jcp.1041270122. [DOI] [PubMed] [Google Scholar]
  19. Mulherkar R., Desai S. J., Rao R. S., Wagle A. S., Deo M. G. Expression of enhancing factor gene and its localization in mouse tissues. Histochemistry. 1991;96(4):367–370. doi: 10.1007/BF00271358. [DOI] [PubMed] [Google Scholar]
  20. Mulherkar R., Rao R. S., Wagle A. S., Patki V., Deo M. G. Enhancing factor, a Paneth cell specific protein from mouse small intestines: predicted amino acid sequence from RT-PCR amplified cDNA and its expression. Biochem Biophys Res Commun. 1993 Sep 30;195(3):1254–1263. doi: 10.1006/bbrc.1993.2179. [DOI] [PubMed] [Google Scholar]
  21. Mulherkar R., Rao R., Rao L., Patki V., Chauhan V. S., Deo M. G. Enhancing factor protein from mouse small intestines belongs to the phospholipase A2 family. FEBS Lett. 1993 Feb 15;317(3):263–266. doi: 10.1016/0014-5793(93)81289-c. [DOI] [PubMed] [Google Scholar]
  22. Mulherkar R., Saraf A., Wagle A., Deo M. G. Purification of the enhancing factor from mouse intestines. FEBS Lett. 1986 Oct 20;207(1):142–144. doi: 10.1016/0014-5793(86)80028-x. [DOI] [PubMed] [Google Scholar]
  23. Murakami M., Kudo I., Inoue K. Molecular nature of phospholipases A2 involved in prostaglandin I2 synthesis in human umbilical vein endothelial cells. Possible participation of cytosolic and extracellular type II phospholipases A2. J Biol Chem. 1993 Jan 15;268(2):839–844. [PubMed] [Google Scholar]
  24. Murakami M., Nakatani Y., Kudo I. Type II secretory phospholipase A2 associated with cell surfaces via C-terminal heparin-binding lysine residues augments stimulus-initiated delayed prostaglandin generation. J Biol Chem. 1996 Nov 22;271(47):30041–30051. doi: 10.1074/jbc.271.47.30041. [DOI] [PubMed] [Google Scholar]
  25. Ono T., Tojo H., Kuramitsu S., Kagamiyama H., Okamoto M. Purification and characterization of a membrane-associated phospholipase A2 from rat spleen. Its comparison with a cytosolic phospholipase A2 S-1. J Biol Chem. 1988 Apr 25;263(12):5732–5738. [PubMed] [Google Scholar]
  26. Pruzanski W., Bogoch E., Stefanski E., Wloch M., Vadas P. Synthesis and release of phospholipase A2 by unstimulated human articular chondrocytes. J Rheumatol. 1990 Oct;17(10):1386–1391. [PubMed] [Google Scholar]
  27. Rosenberg P., Ghassemi A., Condrea E., Dhillon D., Yang C. C. Do chemical modifications dissociate between the enzymatic and pharmacological activities of beta bungarotoxin and notexin? Toxicon. 1989;27(2):137–159. doi: 10.1016/0041-0101(89)90128-1. [DOI] [PubMed] [Google Scholar]
  28. Scott D. L., White S. P., Otwinowski Z., Yuan W., Gelb M. H., Sigler P. B. Interfacial catalysis: the mechanism of phospholipase A2. Science. 1990 Dec 14;250(4987):1541–1546. doi: 10.1126/science.2274785. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Soubeyrand S., Lazure C., Manjunath P. Phospholipase A2 from bovine seminal plasma is a platelet-activating factor acetylhydrolase. Biochem J. 1998 Jan 1;329(Pt 1):41–47. doi: 10.1042/bj3290041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Stetler-Stevenson W. G., Bersch N., Golde D. W. Tissue inhibitor of metalloproteinase-2 (TIMP-2) has erythroid-potentiating activity. FEBS Lett. 1992 Jan 20;296(2):231–234. doi: 10.1016/0014-5793(92)80386-u. [DOI] [PubMed] [Google Scholar]
  31. Wagle A., Desai S., Deo M. G. Immunohistochemical localization of 'enhancing factor', a novel growth modulator, in the mouse small intestines. Cell Biol Int Rep. 1989 Mar;13(3):309–311. doi: 10.1016/0309-1651(89)90154-9. [DOI] [PubMed] [Google Scholar]
  32. van den Bergh C. J., Slotboom A. J., Verheij H. M., de Haas G. H. The role of Asp-49 and other conserved amino acids in phospholipases A2 and their importance for enzymatic activity. J Cell Biochem. 1989 Apr;39(4):379–390. doi: 10.1002/jcb.240390404. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES